EGFR, BRAF and KRAS Status in Patients Undergoing Pulmonary Metastasectomy from Primary Colorectal Carcinoma: A Prospective Follow-Up Study

Repeated Resection of Colorectal Cancer Pulmonary Oligometastases: Pooled Analysis and Prognostic Assessment

(2013) Samer Salah et al.   ANNALS OF SURGICAL ONCOLOGY

Cancer statistics, 2013

(2013) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Somatic Profiling of the Epidermal Growth Factor Receptor Pathway in Tumors from Patients with Advanced Colorectal Cancer Treated with Chemotherapy   Cetuximab

(2013) C. G. Smith et al.   CLINICAL CANCER RESEARCH

Prognostic factors in pulmonary metastasectomy: spotlight on molecular and radiological markers

(2013) Thomas Schweiger et al.   EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY

Incidence and Predictive Factors for Pulmonary Metastases After Curative Resection of Colon Cancer

(2012) Kazuhiro Watanabe et al.   ANNALS OF SURGICAL ONCOLOGY

Risk Factors for Survival after Lung Metastasectomy in Colorectal Cancer Patients: A Systematic Review and Meta-Analysis

(2012) Michel Gonzalez et al.   ANNALS OF SURGICAL ONCOLOGY

Different metastatic pattern according to the KRAS mutational status and site-specific discordance of KRAS status in patients with colorectal cancer

(2012) Mi-Jung Kim et al.   BMC CANCER

Targeting the EGFR signaling pathway in cancer therapy

(2012) Parthasarathy Seshacharyulu et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Molecular Profiling of Colon Tumors: The Search for Clinically Relevant Biomarkers of Progression, Prognosis, Therapeutics, and Predisposition

(2011) Manny D. Bacolod et al.   ANNALS OF SURGICAL ONCOLOGY

Clinical characterization of patients with metastatic colorectal cancer depending on the KRAS status

(2011) Dominik P. Modest et al.   ANTI-CANCER DRUGS

KRAS Mutation Is Associated with Lung Metastasis in Patients with Curatively Resected Colorectal Cancer

(2011) J. Tie et al.   CLINICAL CANCER RESEARCH

Differential gene expression signatures between colorectal cancers with and without KRAS mutations: Crosstalk between the KRAS pathway and other signalling pathways

(2011) Toshiaki Watanabe et al.   EUROPEAN JOURNAL OF CANCER

Pulmonary metastasectomy

(2011) K. Hoetzenecker et al.   European Surgery-Acta Chirurgica Austriaca

Value of Mismatch Repair, KRAS, and BRAF Mutations in Predicting Recurrence and Benefits From Chemotherapy in Colorectal Cancer

(2011) Gordon Hutchins et al.   JOURNAL OF CLINICAL ONCOLOGY

Clinical significance of genetic alterations and expression of epidermal growth factor receptor (EGFR) in head and neck squamous cell carcinomas

(2011) Balázs Szabó et al.   ORAL ONCOLOGY

KRAS and BRAF Mutational Status in Primary Colorectal Tumors and Related Metastatic Sites: Biological and Clinical Implications

(2010) Antoine Italiano et al.   ANNALS OF SURGICAL ONCOLOGY

Epidemiology, management and prognosis of colorectal cancer with lung metastases: a 30-year population-based study

(2010) E. Mitry et al.   GUT

Reported Outcome Factors for Pulmonary Resection in Metastatic Colorectal Cancer

(2010) Joachim Pfannschmidt et al.   Journal of Thoracic Oncology

Overexpression of SGLT1 and EGFR in colorectal cancer showing a correlation with the prognosis

(2010) Gui Fang Guo et al.   MEDICAL ONCOLOGY

KRAS Mutation in Colon Cancer: A Marker of Resistance to EGFR-I Therapy

(2009) Ahmad D. Siddiqui et al.   ANNALS OF SURGICAL ONCOLOGY

Pulmonary metastasectomy in colorectal cancer: Time for a trial

(2009) T. Treasure et al.   EJSO

Analysis of PTEN, BRAF, and EGFR Status in Determining Benefit From Cetuximab Therapy in Wild-Type KRAS Metastatic Colon Cancer

(2009) Pierre Laurent-Puig et al.   JOURNAL OF CLINICAL ONCOLOGY

KRAS Mutations in Primary Colorectal Cancer Tumors and Related Metastases: A Potential Role in Prediction of Lung Metastasis

(2009) Paloma Cejas et al.   PLoS One

Tyrosine kinase expression in pulmonary metastases and paired primary tumors

(2009) Bernd M. Muehling et al.   Interactive Cardiovascular and Thoracic Surgery